Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continued Pressure for Alveolar Protection (CPAP Trial)

NCT: NCT07417111 · RECRUITING

NCT IDNCT07417111
StatusRECRUITING
Start Date2026-11-05
Completion2029-01-30
SponsorNICHD Neonatal Research Network (NETWORK)
First posted
Last updated

Brief Summary

The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑